almediah.fr
» » Farnesyltransferase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)

Download Farnesyltransferase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) eBook

by Saïd M. Sebti,Andrew D. Hamilton

Download Farnesyltransferase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) eBook
ISBN:
0896036294
Author:
Saïd M. Sebti,Andrew D. Hamilton
Category:
Medicine & Health Sciences
Language:
English
Publisher:
Humana Press; 2001 edition (October 22, 2000)
Pages:
280 pages
EPUB book:
1334 kb
FB2 book:
1183 kb
DJVU:
1864 kb
Other formats
doc lit azw mbr
Rating:
4.3
Votes:
606


Illuminating and richly detailed, Farnesyltransferase Inhibitors in Cancer Therapy constitutes today's standard reference for the pathbreaking use of FTIs and GGTIs in anticancer therapy and offers basic and clinical investigators a comprehensive treatment of the scientific an. .

Illuminating and richly detailed, Farnesyltransferase Inhibitors in Cancer Therapy constitutes today's standard reference for the pathbreaking use of FTIs and GGTIs in anticancer therapy and offers basic and clinical investigators a comprehensive treatment of the scientific and medical aspects of farnesyltransferase inhibitors.

Farnesyltransferase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development). Said M. Sebti, Andrew D. Hamilton. Скачать (pdf, . 1 Mb). Download (pdf, .

Illuminating and richly detailed, Farnesyltransferase Inhibitors in Cancer Therapy constitutes today's standard reference for the pathbreaking use of FTIs and GGTIs in anticancer therapy and offers basic and clinical investigators a comprehensive treatment of the scientific an.

Cancer drug discovery and development. Bibliography, etc. Note: Includes bibliographical references and index. On this site it is impossible to download the book, read the book online or get the contents of a book. The administration of the site is not responsible for the content of the site. The data of catalog based on open source database. All rights are reserved by their owners.

Inhibitors of farnesyltransferase have been developed as novel anticancer agents for .

Inhibitors of farnesyltransferase have been developed as novel anticancer agents for several cancers. Do you want to read the rest of this article? Request full-text.

Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.

Are you sure you want to remove Farnesyltransferase Inhibitors in Cancer Therapy (Cancer Drug .

Are you sure you want to remove Farnesyltransferase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) from your list? Farnesyltransferase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development). Published January 15, 2001 by Humana Press.

Дата издания: 2001 Серия: Cancer Drug Discovery and Development Язык: ENG Издание: 2001 e.

Illuminating and richly detailed, Farnesyltransferase Inhibitors in Cancer Therapy constitutes todays standard reference for the pathbreaking use of FTIs and GGTIs in anticancer therapy and offers basic and clinical investigators a comprehensive treatment of the scientific and medical aspects of farnesyltransferase inhibitors.

Illuminating and richly detailed, Farnesyltransferase Inhibitors in Cancer Therapy constitutes today's standard reference for the pathbreaking use of FTIs and GGTIs in anticancer therapy and offers basic and clinical investigators a comprehensive treatment of the scientific and medical aspects of farnesyltransferase inhibitors. 1. Andrew D.

Cutting-edge researchers describe their efforts to design, synthesize, and evaluate the biological activities of farensyltransferase inhibitors (FTIs); geranylgeranyltransferase inhibitors (GGTIs) are also discussed as potential anticancer drugs. The authors survey in detail such inhibitors as CAAX box peptidomimetics, FPP mimics, and bisubstrate transition state analogs, and critically review their uses in combination with radiation and other cytotoxic agents, such as gemcitabine, cisplatin, and taxanes. Illuminating and richly detailed, Farnesyltransferase Inhibitors in Cancer Therapy constitutes today's standard reference for the pathbreaking use of FTIs and GGTIs in anticancer therapy and offers basic and clinical investigators a comprehensive treatment of the scientific and medical aspects of farnesyltransferase inhibitors.